Clinical Trial Update: Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

View source ↗

Summary

An ongoing University of Rochester clinical trial investigates monitoring minimal residual disease in patients with acute myeloid leukemia or myelodysplastic sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: University of Rochester | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Status: RECRUITING